Literature DB >> 10531307

Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.

M Krych-Goldberg1, R E Hauhart, V B Subramanian, B M Yurcisin, D L Crimmins, D E Hourcade, J P Atkinson.   

Abstract

The goal of this study was to identify the site(s) in CR1 that mediate the dissociation of the C3 and C5 convertases. To that end, truncated derivatives of CR1 whose extracellular part is composed of 30 tandem repeating modules, termed complement control protein repeats (CCPs), were generated. Site 1 (CCPs 1-3) alone mediated the decay acceleration of the classical and alternative pathway C3 convertases. Site 2 (CCPs 8-10 or the nearly identical CCPs 15-17) had one-fifth the activity of site 1. In contrast, for the C5 convertase, site 1 had only 0.5% of the decay accelerating activity, while site 2 had no detectable activity. Efficient C5 decay accelerating activity was detected in recombinants that carried both site 1 and site 2. The activity was reduced if the intervening repeats between site 1 and site 2 were deleted. The results indicate that, for the C5 convertases, decay accelerating activity is mediated primarily by site 1. A properly spaced site 2 has an important auxiliary role, which may involve its C3b binding capacity. Moreover, using homologous substitution mutagenesis, residues important in site 1 for dissociating activity were identified. Based on these results, we generated proteins one-fourth the size of CR1 but with enhanced decay accelerating activity for the C3 convertases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531307     DOI: 10.1074/jbc.274.44.31160

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement.

Authors:  Pawit Somnuke; Richard E Hauhart; John P Atkinson; Michael S Diamond; Panisadee Avirutnan
Journal:  Virology       Date:  2011-03-22       Impact factor: 3.616

Review 2.  CR1 in Alzheimer's disease.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Ping Wang; Lei Cao; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

3.  Identification of a complement receptor 1 peptide for inhibition of immune hemolysis.

Authors:  Jin Yu; Susanne Heck; Asim Debnath; Karina Yazdanbakhsh
Journal:  Biochem Biophys Res Commun       Date:  2006-12-11       Impact factor: 3.575

4.  Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.

Authors:  Wai-Hong Tham; Christoph Q Schmidt; Richard E Hauhart; Mara Guariento; Patience B Tetteh-Quarcoo; Sash Lopaticki; John P Atkinson; Paul N Barlow; Alan F Cowman
Journal:  Blood       Date:  2011-06-17       Impact factor: 22.113

5.  Amino acid patterns within short consensus repeats define conserved duplicons shared by genes of the RCA complex.

Authors:  Craig A McLure; Roger L Dawkins; Joseph F Williamson; Richard A Davies; Jemma Berry; Longman-Jacobsen Natalie; Rebecca Laird; Silvana Gaudieri
Journal:  J Mol Evol       Date:  2004-08       Impact factor: 2.395

6.  Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.

Authors:  Hyon Ju Park; Mara Guariento; Mateusz Maciejewski; Richard Hauhart; Wai-Hong Tham; Alan F Cowman; Christoph Q Schmidt; Haydyn D T Mertens; M Kathryn Liszewski; Dennis E Hourcade; Paul N Barlow; John P Atkinson
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

7.  Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.

Authors:  Panisadee Avirutnan; Anja Fuchs; Richard E Hauhart; Pawit Somnuke; Soonjeon Youn; Michael S Diamond; John P Atkinson
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

8.  Dissection of functional sites in herpesvirus saimiri complement control protein homolog.

Authors:  Malik Johid Reza; Ashish Kamble; Muzammil Ahmad; Musti V Krishnasastry; Arvind Sahu
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

9.  Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities.

Authors:  Akhilesh K Singh; Viveka Nand Yadav; Kalyani Pyaram; Jayati Mullick; Arvind Sahu
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

Review 10.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.